04.04.2017 Views

CRUNCH

cityam-2017-04-04-58e2d9137c434

cityam-2017-04-04-58e2d9137c434

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CITYAM.COM<br />

TUESDAY 4 APRIL 2017<br />

NEWS<br />

09<br />

Talk of deadline<br />

extension hits<br />

Toshiba’s shares<br />

COURTNEY GOLDSMITH<br />

@courtneynoelg<br />

SHARES in troubled Japanese conglomerate<br />

Toshiba fell more than nine<br />

per cent yesterday during trading,<br />

after sources warned it is expected to<br />

miss a third results deadline.<br />

The firm’s stock closed 5.47 per cent<br />

lower as sources told Reuters Toshiba’s<br />

auditor, PwC, has questions about its<br />

financial results for the business year<br />

through March 2016.<br />

Toshiba was originally meant to file<br />

its quarterly earnings for the period<br />

from October to December in February.<br />

It has twice received approval to<br />

extend the deadline.<br />

In March, the group said it needed<br />

more time to investigate an “alleged<br />

occurrence of inappropriate pressures<br />

by certain senior managers” surrounding<br />

the purchase of CB&I Stone<br />

& Webster, a nuclear construction<br />

company, by its US unit, Westinghouse.<br />

Westinghouse filed for bankruptcy<br />

protection last week after incurring<br />

£5bn in impairment charges at US<br />

nuclear new builds.<br />

The writedowns could push<br />

Toshiba’s net loss for the year to ¥1<br />

trillion (£7.2bn) compared with a previous<br />

estimate of ¥390bn, the company<br />

warned.<br />

A Toshiba spokesman told Reuters<br />

the possible postponement was not<br />

something the company had announced<br />

and that it was preparing to<br />

make the earnings announcement by<br />

11 April.<br />

The group has been threatened with<br />

a delisting from the Tokyo Stock Exchange<br />

if it misses a deadline.<br />

Last week, the firm’s shareholders<br />

approved plans to split off the company’s<br />

prized flash memory chip business<br />

to cover Westinghouse’s losses.<br />

Angry investors lashed out at chief<br />

executive Satoshi Tsunakawa and others,<br />

with one calling Toshiba a “laughing<br />

stock around the world”.<br />

The FTSE 250 security company’s shares jumped last month on strong results<br />

G4S pushes transformation plan<br />

with sale of US prison contract<br />

COURTNEY GOLDSMITH<br />

@courtneynoelg<br />

GLOBAL security firm G4S yesterday<br />

sold its US youth detention centres<br />

for $56.5m (£45.1m) in cash, with<br />

proceeds earmarked for “corporate<br />

purposes”.<br />

The UK-based company sold its<br />

youth services unit, which operates in<br />

Florida, Texas and Tennessee, to<br />

BHSB, a US health care services<br />

company.<br />

Chief executive Ashley Almanza<br />

said the sale is part of a portfolio<br />

management programme started in<br />

2013 to improve the company’s<br />

strategic, commercial and<br />

operational focus.<br />

In the year to the end of December,<br />

G4S’ youth services unit reported pretax<br />

profit of $5.1m.<br />

Apax Partners<br />

bags Israeli<br />

firm for $397m<br />

TOVA COHEN<br />

BRITISH private equity firm Apax<br />

Partners has agreed to buy Israel’s<br />

Syneron Medical, a non-surgical<br />

aesthetic device company, for $11<br />

per share in cash, or a total of<br />

$397m (£317.52m), the companies<br />

said yesterday.<br />

The share price represents a 15<br />

per cent premium to Syneron’s 90-<br />

day average closing price through 31<br />

March, and a 33 per cent premium<br />

to its 90-day average closing price<br />

through 10 February, the last<br />

trading day prior to media<br />

speculation of a transaction.<br />

Syneron says its products have a<br />

range of applications, like body<br />

contouring, hair removal and<br />

wrinkle reduction. The products are<br />

sold under two brands, Syneron and<br />

Candela.<br />

“We have identified the medical<br />

aesthetics market as a highly<br />

attractive investment area given its<br />

long-term growth prospects,” said<br />

Apax’s Steven Dyson.<br />

The agreement includes a “goshop”<br />

period which ends on 9 May,<br />

in which Syneron Candela will<br />

solicit and possibly enter into<br />

negotiations over alternative<br />

proposals from third parties. Reuters<br />

If you want to make the most of your £15,240 ISA allowance before the<br />

5 April deadline, but don’t have time to choose funds, turn to our ISA<br />

Cash Park. It lets you hold some or all of this year’s ISA allowance in cash,<br />

so you can decide which funds to invest in later.<br />

When you’re ready, our award-winning guidance can help you make your<br />

choice. It offers helpful guides, online tools and fund recommendations,<br />

as well as regular market insights.<br />

Secure your ISA allowance today.<br />

Apply online at fidelity.co.uk or call us on 0800 368 1721.<br />

Please remember that the value of investments can go down as well<br />

as up, so you may not get back the amount you invest. The value of<br />

tax savings and eligibility to invest in an ISA depend on individual<br />

circumstances and all tax rules may change in the future. Fidelity’s<br />

guidance service is not a personal recommendation.<br />

UKM0317/19206/SSO/0417

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!